Ireland vs Uganda: Antiretroviral therapy coverage for PMTCT
Ireland
100.0%
in 2024
Uganda
100.0%
in 2024
Ireland rank
1st
Uganda rank
1st
Antiretroviral therapy coverage for PMTCT over time
- Ireland
- Uganda
How they compare
Ireland currently reports 100.0% against 100.0% in Uganda, a difference of 0.0%.
The two have swapped places 3 times across 19 shared years of data; in 2000 it was Ireland ahead.
Ireland ranks 1st and Uganda ranks 1st of 84 countries.
Ireland has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Ireland | Uganda | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 90.0% | 21.8% | 68.2% | Ireland |
| 2010s | 100.0% | 100.0% | 0.0% | — |
| 2020s | 100.0% | 98.5% | 1.5% | Ireland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Ireland or Uganda?
- Ireland, at 100.0% against 100.0% in Uganda as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between Ireland and Uganda?
- 0.0%, with Ireland ahead.
- How many years of comparable data are there for Ireland and Uganda?
- 19 years are reported by both, from 2000 to 2024.
- How do Ireland and Uganda rank globally for antiretroviral therapy coverage for pmtct?
- Ireland ranks 1st and Uganda ranks 1st of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).